Sun Pharma inks global licensing agreement to commercialise Philogen’s anti-cancer immunotherapy

As per the terms of the agreement, Sun Pharma will have the exclusive worldwide rights for commercialising Fibromun.

As per the terms of the agreement, Sun Pharma will have the exclusive worldwide rights for commercialising Fibromun.

The proceeds from the fresh issue to the extent of ₹625.5 crore will be used for funding working capital requirements of the company, and for general corporate purposes.

The bank’s overall total business as of September 30, 2024, stood at ₹1,76,135 crore.

The contract covers the maintenance of simulators developed by Zen for a five-year period.

Among other sectors, there has been a shift in focus toward pharmaceuticals and private sector banks, said Shreyas Devalkar, Head of Equity at Axis Mutual Fund said.

It will be important to watch out for any potential impact on Angel One’s volumes as a result of this move.

The Bajaj Group company beat estimates with an overall jump of 20%, compared to the same month last year.

Promoters of NCC held a 22% stake in the company at the end of the June quarter. Rekha Rakesh Jhunjhunwala held a 10.63% stake in the company.

RITES Share Price | The broad consideration for the order is $4.28 million (₹35.87 crore approx). The order has to be executed within six months with a one-year warranty, the company informed the bourses.

At the end of the June quarter, Godrej Properties had reported a net debt of ₹7,432 crore, which is higher than the ₹6,198 crore figure at the end of the March quarter and ₹5,298 crore at the end of the…